Home / LYTIX.OL : OSL

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does LYTIX.OL make money? Does LYTIX.OL have pricing power? What's the Earnings Whisper? Will LYTIX.OL profit more as the business scales? What is LYTIX.OL's management track record? Is LYTIX.OL's current price justified?

Lytix Biopharma AS

NOK 7.90 -$2.08 (-20.84%)

OSL · 30 Oct 2026 15:25 UTC

Previous Close

NOK 7.74

Day Range

NOK 7.56NOK 7.98

Year Range

NOK 7.24NOK 11.90

Market Cap

607.51M

AVG Volume

26.98K

Trailing/Forward PE

-6.08/-

PEG ratio

-0.12

Dividend Yield

Next Earnings Date

2026-11-11

Primary Exchange

Oslo Stock Exchange

Revenue (NOK) · A

LYTIX.OL Revenue (NOK) by year
Period	Revenue (NOK)
2025	0
2024	11.13M
2023	3.99M
2022	1.41M
2021	17K

Net Income (NOK) · A

LYTIX.OL Net Income (NOK) by year
Period	Net Income (NOK)
2025	-59.97M
2024	-94.27M
2023	-87.9M
2022	-56.01M
2021	-48.05M

Operating Income (NOK) · A

LYTIX.OL Operating Income (NOK) by year
Period	Operating Income (NOK)
2025	-63.99M
2024	-95.9M
2023	-96.78M
2022	-65.69M
2021	-48.02M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (NOK) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 11 Nov 2026.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Lytix Biopharma AS

Earnings: LYTIX.OL

Video analysis: LYTIX.OL

News: LYTIX.OL

Similar companies